From: Efficacy of a self-management program in patients with chronic viral hepatitis in China
Variable | Intervention group | Usual care group | p value |
---|---|---|---|
(n = 30) | (n = 30) | ||
Characteristics | n (%) or | n (%) or | |
mean ± SD | mean ± SD | ||
Females | 15 (50.0) | 6 (20.0) | 0.029a* |
Employed | 25 (83.3) | 22 (73.3) | 0.532a |
Marital status: married | 26 (86.7) | 26 (86.7) | 1.000a |
Living with another person | 28 (93.3) | 27 (90.0) | 1.000a |
Age (years) | 33.2 ± 7.29 | 36.6 ± 10.56 | 0.152b |
Subject profiles | |||
Comorbidity | 25 (83.3) | 22 (73.3) | 0.532a |
Diabetes mellitus | 27 (90.0) | 28 (93.3) | 1.000a |
Recurrent history of liver disease in the past 2 years | 19 (63.3) | 14 (46.7) | 0.299a |
Use of insulin | 29 (96.7) | 28 (93.3) | 1.000a |
Treatment regimen | |||
Antiviral medicine | 11 (36.7) | 9 (30.0) | 0.785a |
Anti-fibrosis therapy | 13 (43.3) | 15 (50.0) | 0.796a |
Immunotherapy | 4 (13.3) | 6 (20.0) | 0.731a |
Liver protection therapy | 27 (90.0) | 28 (93.9) | 1.000a |
Peg interferon | 11 (36.7) | 14 (46.7) | 0.601a |
Types of hepatitis | |||
Hepatitis B | 26 (86.7) | 26 (86.7) | 1.000a |
Hepatitis C | 4 (13.3) | 4 (13.3) |